Medical 21, Inc.
About Medical 21, Inc.
Medical 21, Inc. is a Minnesota corporation organized in February 2016 to produce artificial grafts that eliminate the harvesting of vessels for cardiac bypass surgery, improving patient quality of life and reducing healthcare system costs. The company is currently in the developmental stages with its office in Plymouth, Minnesota. It is the eighth medical device company founded by Manny Villafaña, who previously led seven companies to IPO.
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised $550,000 via private placement at $5.80 per share.
- Founded in 2016 by serial medtech entrepreneur Manny Villafaña in Plymouth, MN.
- Developing artificial grafts to eliminate vessel harvesting in cardiac bypass surgery.
- Company remains in developmental stages with focus on improving patient outcomes and reducing costs.
Ask StreetZero about Medical 21, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account